203 related articles for article (PubMed ID: 32719554)
1. A pan-cancer analysis reveals nonstop extension mutations causing SMAD4 tumour suppressor degradation.
Dhamija S; Yang CM; Seiler J; Myacheva K; Caudron-Herger M; Wieland A; Abdelkarim M; Sharma Y; Riester M; Groß M; Maurer J; Diederichs S
Nat Cell Biol; 2020 Aug; 22(8):999-1010. PubMed ID: 32719554
[TBL] [Abstract][Full Text] [Related]
2. Loss of function SMAD4 nonstop mutations in human cancer.
Bauer AH; Basta DW; Hornick JL; Dong F
Histopathology; 2023 Jun; 82(7):1098-1104. PubMed ID: 36740808
[TBL] [Abstract][Full Text] [Related]
3. Acute myelogenous leukemia-derived SMAD4 mutations target the protein to ubiquitin-proteasome degradation.
Yang L; Wang N; Tang Y; Cao X; Wan M
Hum Mutat; 2006 Sep; 27(9):897-905. PubMed ID: 16865698
[TBL] [Abstract][Full Text] [Related]
4. A meta-analysis of single base-pair substitutions in translational termination codons ('nonstop' mutations) that cause human inherited disease.
Hamby SE; Thomas NS; Cooper DN; Chuzhanova N
Hum Genomics; 2011 May; 5(4):241-64. PubMed ID: 21712188
[TBL] [Abstract][Full Text] [Related]
5.
McCarthy AJ; Chetty R
J Clin Pathol; 2018 Aug; 71(8):661-664. PubMed ID: 29720405
[TBL] [Abstract][Full Text] [Related]
6. ALK phosphorylates SMAD4 on tyrosine to disable TGF-β tumour suppressor functions.
Zhang Q; Xiao M; Gu S; Xu Y; Liu T; Li H; Yu Y; Qin L; Zhu Y; Chen F; Wang Y; Ding C; Wu H; Ji H; Chen Z; Zu Y; Malkoski S; Li Y; Liang T; Ji J; Qin J; Xu P; Zhao B; Shen L; Lin X; Feng XH
Nat Cell Biol; 2019 Feb; 21(2):179-189. PubMed ID: 30664791
[TBL] [Abstract][Full Text] [Related]
7. Rkr1/Ltn1 Ubiquitin Ligase-mediated Degradation of Translationally Stalled Endoplasmic Reticulum Proteins.
Crowder JJ; Geigges M; Gibson RT; Fults ES; Buchanan BW; Sachs N; Schink A; Kreft SG; Rubenstein EM
J Biol Chem; 2015 Jul; 290(30):18454-66. PubMed ID: 26055716
[TBL] [Abstract][Full Text] [Related]
8. SMAD4 suppresses AURKA-induced metastatic phenotypes via degradation of AURKA in a TGFβ-independent manner.
Jia L; Lee HS; Wu CF; Kundu J; Park SG; Kim RN; Wang LH; Erkin ÖC; Choi JS; Chae SW; Yang HB; Choi YL; Shin YK
Mol Cancer Res; 2014 Dec; 12(12):1779-95. PubMed ID: 25061104
[TBL] [Abstract][Full Text] [Related]
9. Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4.
Qiu W; Schönleben F; Li X; Su GH
Cancer Lett; 2007 Jan; 245(1-2):163-70. PubMed ID: 16478646
[TBL] [Abstract][Full Text] [Related]
10. Somatic alterations in juvenile polyps from BMPR1A and SMAD4 mutation carriers.
Blatter RH; Plasilova M; Wenzel F; Gokaslan ST; Terracciano L; Ashfaq R; Heinimann K
Genes Chromosomes Cancer; 2015 Sep; 54(9):575-82. PubMed ID: 26171675
[TBL] [Abstract][Full Text] [Related]
11. A genomic screen in yeast reveals novel aspects of nonstop mRNA metabolism.
Wilson MA; Meaux S; van Hoof A
Genetics; 2007 Oct; 177(2):773-84. PubMed ID: 17660569
[TBL] [Abstract][Full Text] [Related]
12. SMAD4 gene promoter mutations in patients with thyroid tumors.
Nikolic A; Ristanovic M; Zivaljevic V; Rankov AD; Radojkovic D; Paunovic I
Exp Mol Pathol; 2015 Aug; 99(1):100-3. PubMed ID: 26079547
[TBL] [Abstract][Full Text] [Related]
13. Loss of Smad4 function in pancreatic tumors: C-terminal truncation leads to decreased stability.
Maurice D; Pierreux CE; Howell M; Wilentz RE; Owen MJ; Hill CS
J Biol Chem; 2001 Nov; 276(46):43175-81. PubMed ID: 11553622
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression.
Wang LH; Kim SH; Lee JH; Choi YL; Kim YC; Park TS; Hong YC; Wu CF; Shin YK
Clin Cancer Res; 2007 Jan; 13(1):102-10. PubMed ID: 17200344
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial mutations in human cancer: Curation of translation.
Caudron-Herger M; Diederichs S
RNA Biol; 2018 Jan; 15(1):62-69. PubMed ID: 28873329
[TBL] [Abstract][Full Text] [Related]
16. The role of TGF-β/SMAD4 signaling in cancer.
Zhao M; Mishra L; Deng CX
Int J Biol Sci; 2018; 14(2):111-123. PubMed ID: 29483830
[TBL] [Abstract][Full Text] [Related]
17. Genetic analyses of isolated high-grade pancreatic intraepithelial neoplasia (HG-PanIN) reveal paucity of alterations in TP53 and SMAD4.
Hosoda W; Chianchiano P; Griffin JF; Pittman ME; Brosens LA; Noë M; Yu J; Shindo K; Suenaga M; Rezaee N; Yonescu R; Ning Y; Albores-Saavedra J; Yoshizawa N; Harada K; Yoshizawa A; Hanada K; Yonehara S; Shimizu M; Uehara T; Samra JS; Gill AJ; Wolfgang CL; Goggins MG; Hruban RH; Wood LD
J Pathol; 2017 May; 242(1):16-23. PubMed ID: 28188630
[TBL] [Abstract][Full Text] [Related]
18. Differential ubiquitination defines the functional status of the tumor suppressor Smad4.
Morén A; Hellman U; Inada Y; Imamura T; Heldin CH; Moustakas A
J Biol Chem; 2003 Aug; 278(35):33571-82. PubMed ID: 12794086
[TBL] [Abstract][Full Text] [Related]
19. A nonstop variant in REEP1 causes peripheral neuropathy by unmasking a 3'UTR-encoded, aggregation-inducing motif.
Bock AS; Günther S; Mohr J; Goldberg LV; Jahic A; Klisch C; Hübner CA; Biskup S; Beetz C
Hum Mutat; 2018 Feb; 39(2):193-196. PubMed ID: 29124833
[TBL] [Abstract][Full Text] [Related]
20. Juvenile polyposis, hereditary hemorrhagic telangiectasia, and early onset colorectal cancer in patients with SMAD4 mutation.
Schwenter F; Faughnan ME; Gradinger AB; Berk T; Gryfe R; Pollett A; Cohen Z; Gallinger S; Durno C
J Gastroenterol; 2012 Jul; 47(7):795-804. PubMed ID: 22331366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
